BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26781030)

  • 1. ASGPR-Mediated Uptake of Multivalent Glycoconjugates for Drug Delivery in Hepatocytes.
    Monestier M; Charbonnier P; Gateau C; Cuillel M; Robert F; Lebrun C; Mintz E; Renaudet O; Delangle P
    Chembiochem; 2016 Apr; 17(7):590-4. PubMed ID: 26781030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Acetylgalactosamine Block-co-Polycations Form Stable Polyplexes with Plasmids and Promote Liver-Targeted Delivery.
    Dhande YK; Wagh BS; Hall BC; Sprouse D; Hackett PB; Reineke TM
    Biomacromolecules; 2016 Mar; 17(3):830-40. PubMed ID: 26854615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asialoglycoprotein Receptor-Mediated Gene Delivery to Hepatocytes Using Galactosylated Polymers.
    Thapa B; Kumar P; Zeng H; Narain R
    Biomacromolecules; 2015 Sep; 16(9):3008-20. PubMed ID: 26258607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry.
    Sakashita M; Mochizuki S; Sakurai K
    Bioorg Med Chem; 2014 Oct; 22(19):5212-9. PubMed ID: 25155912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of intrahepatocyte copper(I) chelators as drug candidates for Wilson's disease.
    Gateau C; Delangle P
    Ann N Y Acad Sci; 2014 May; 1315():30-6. PubMed ID: 24611802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting.
    Bernardes GJ; Kikkeri R; Maglinao M; Laurino P; Collot M; Hong SY; Lepenies B; Seeberger PH
    Org Biomol Chem; 2010 Nov; 8(21):4987-96. PubMed ID: 20820666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kukoamine B promotes TLR4-independent lipopolysaccharide uptake in murine hepatocytes.
    Yang D; Zheng X; Wang N; Fan S; Yang Y; Lu Y; Chen Q; Liu X; Zheng J
    Oncotarget; 2016 Sep; 7(36):57498-57513. PubMed ID: 27542278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
    D'Souza AA; Devarajan PV
    J Control Release; 2015 Apr; 203():126-39. PubMed ID: 25701309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sulfur tripod glycoconjugate that releases a high-affinity copper chelator in hepatocytes.
    Pujol AM; Cuillel M; Jullien AS; Lebrun C; Cassio D; Mintz E; Gateau C; Delangle P
    Angew Chem Int Ed Engl; 2012 Jul; 51(30):7445-8. PubMed ID: 22730309
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression.
    Willoughby JLS; Chan A; Sehgal A; Butler JS; Nair JK; Racie T; Shulga-Morskaya S; Nguyen T; Qian K; Yucius K; Charisse K; van Berkel TJC; Manoharan M; Rajeev KG; Maier MA; Jadhav V; Zimmermann TS
    Mol Ther; 2018 Jan; 26(1):105-114. PubMed ID: 28988716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of a Triantennary Quinoline Glycoconjugate with the Asialoglycoprotein Receptor.
    Palit S; Banerjee S; Mahata T; Niyogi S; Das T; Sova Mandi C; Chakrabarti P; Dutta S
    ChemMedChem; 2021 Jul; 16(14):2211-2216. PubMed ID: 33860988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma.
    Petrov RA; Mefedova SR; Yamansarov EY; Maklakova SY; Grishin DA; Lopatukhina EV; Burenina OY; Lopukhov AV; Kovalev SV; Timchenko YV; Ondar EE; Ivanenkov YA; Evteev SA; Vaneev AN; Timoshenko RV; Klyachko NL; Erofeev AS; Gorelkin PV; Beloglazkina EK; Majouga AG
    Mol Pharm; 2021 Jan; 18(1):461-468. PubMed ID: 33264010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Evaluation of New Trivalent Ligands for Hepatocyte Targeting via the Asialoglycoprotein Receptor.
    Reshitko GS; Yamansarov EY; Evteev SA; Lopatukhina EV; Shkil' DO; Saltykova IV; Lopukhov AV; Kovalev SV; Lobov AN; Kislyakov IV; Burenina OY; Klyachko NL; Garanina AS; Dontsova OA; Ivanenkov YA; Erofeev AS; Gorelkin PV; Beloglazkina EK; Majouga AG
    Bioconjug Chem; 2020 May; 31(5):1313-1319. PubMed ID: 32379426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligands of the asialoglycoprotein receptor for targeted gene delivery, part 1: Synthesis of and binding studies with biotinylated cluster glycosides containing N-acetylgalactosamine.
    Westerlind U; Westman J; Törnquist E; Smith CI; Oscarson S; Lahmann M; Norberg T
    Glycoconj J; 2004; 21(5):227-41. PubMed ID: 15486455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte targeting and intracellular copper chelation by a thiol-containing glycocyclopeptide.
    Pujol AM; Cuillel M; Renaudet O; Lebrun C; Charbonnier P; Cassio D; Gateau C; Dumy P; Mintz E; Delangle P
    J Am Chem Soc; 2011 Jan; 133(2):286-96. PubMed ID: 21155609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new splice variant of the major subunit of human asialoglycoprotein receptor encodes a secreted form in hepatocytes.
    Liu J; Hu B; Yang Y; Ma Z; Yu Y; Liu S; Wang B; Zhao X; Lu M; Yang D
    PLoS One; 2010 Sep; 5(9):e12934. PubMed ID: 20886072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological roles of asialoglycoprotein receptors (ASGPRs) variants and recent advances in hepatic-targeted delivery of therapeutic molecules via ASGPRs.
    Hu J; Liu J; Yang D; Lu M; Yin J
    Protein Pept Lett; 2014; 21(10):1025-30. PubMed ID: 24975671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of lanthanide(III) chelates of DOTA-type glycoconjugates to the hepatic asyaloglycoprotein receptor: cell internalization and animal imaging studies.
    Prata MI; Santos AC; Torres S; André JP; Martins JA; Neves M; García-Martín ML; Rodrigues TB; López-Larrubia P; Cerdán S; Geraldes CF
    Contrast Media Mol Imaging; 2006; 1(6):246-58. PubMed ID: 17191765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric analysis of asialoglycoprotein receptor expression predicts hepatic functional reserve after hepatectomy.
    Ke Z; Li J; Zhe J; Liang LB; Yan L; Yi M
    J Coll Physicians Surg Pak; 2014 Nov; 24(11):820-4. PubMed ID: 25404440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capacity limits of asialoglycoprotein receptor-mediated liver targeting.
    Bon C; Hofer T; Bousquet-Mélou A; Davies MR; Krippendorff BF
    MAbs; 2017; 9(8):1360-1369. PubMed ID: 28876162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.